Podocyte number in normotensive type 1 diabetic patients with albuminuria - PubMed
Clinical Trial
. 2002 Oct;51(10):3083-9.
doi: 10.2337/diabetes.51.10.3083.
Affiliations
- PMID: 12351451
- DOI: 10.2337/diabetes.51.10.3083
Clinical Trial
Podocyte number in normotensive type 1 diabetic patients with albuminuria
Kathryn E White et al. Diabetes. 2002 Oct.
Abstract
We estimated glomerular cell number in 50 normotensive type 1 diabetic patients with raised albumin excretion rate (AER) and investigated any change after 3 years in a subgroup of 16 placebo-treated patients. Biopsies from 10 normal kidney donors were used as controls. Mesangial and endothelial cell number was increased in the 50 diabetic patients at the start of the study compared with control subjects. There was no difference in podocyte number. Glomerular volume was increased in diabetic patients, but surface area of glomerular basement membrane (GBM) underlying the podocytes did not differ between groups. AER correlated positively with mesangial cell number in microalbuminuric patients (r = 0.44, P = 0.012) and negatively with podocyte number in proteinuric patients (r = -0.48, P = 0.040). In the 16 placebo-treated patients, glomerular volume increased after 3 years owing to matrix accumulation and increased GBM surface area. Although overall cell number did not differ significantly from baseline, the decrease in podocyte number during follow-up correlated with AER at follow-up (r = -0.72, P = 0.002). In conclusion, cross-sectional analysis of podocyte number in type 1 diabetic patients with raised AER but normal blood pressure shows no significant reduction compared with nondiabetic control subjects. Longitudinal data provide evidence for an association between podocyte loss and AER, but whether cellular changes are a response to, a cause of, or concomitant with the progression of nephropathy remains uncertain.
Similar articles
-
Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M. Toyoda M, et al. Diabetes. 2007 Aug;56(8):2155-60. doi: 10.2337/db07-0019. Epub 2007 May 29. Diabetes. 2007. PMID: 17536064
-
Moriyama T, Oka K, Ueda H, Imai E. Moriyama T, et al. Clin Exp Nephrol. 2004 Sep;8(3):230-6. doi: 10.1007/s10157-004-0303-1. Clin Exp Nephrol. 2004. PMID: 15480900
-
Wolf G, Chen S, Ziyadeh FN. Wolf G, et al. Diabetes. 2005 Jun;54(6):1626-34. doi: 10.2337/diabetes.54.6.1626. Diabetes. 2005. PMID: 15919782 Review.
-
Structural involvement in type 1 and type 2 diabetic nephropathy.
Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P. Dalla Vestra M, et al. Diabetes Metab. 2000 Jul;26 Suppl 4:8-14. Diabetes Metab. 2000. PMID: 10922968 Review.
Cited by
-
A previously unrecognized role of C3a in proteinuric progressive nephropathy.
Morigi M, Locatelli M, Rota C, Buelli S, Corna D, Rizzo P, Abbate M, Conti D, Perico L, Longaretti L, Benigni A, Zoja C, Remuzzi G. Morigi M, et al. Sci Rep. 2016 Jun 27;6:28445. doi: 10.1038/srep28445. Sci Rep. 2016. PMID: 27345360 Free PMC article.
-
[Ketone Body Metabolism and Renal Diseases].
Liu Y, Ma L, Fu P. Liu Y, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1091-1096. doi: 10.12182/20231160202. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 38162055 Free PMC article. Review. Chinese.
-
Quantitative podocyte parameters predict human native kidney and allograft half-lives.
Naik AS, Afshinnia F, Cibrik D, Hodgin JB, Wu F, Zhang M, Kikuchi M, Wickman L, Samaniego M, Bitzer M, Wiggins JE, Ojo A, Li Y, Wiggins RC. Naik AS, et al. JCI Insight. 2016;1(7):e86943. doi: 10.1172/jci.insight.86943. Epub 2016 May 19. JCI Insight. 2016. PMID: 27280173 Free PMC article.
-
Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes.
Locatelli M, Zoja C, Zanchi C, Corna D, Villa S, Bolognini S, Novelli R, Perico L, Remuzzi G, Benigni A, Cassis P. Locatelli M, et al. Sci Rep. 2020 May 21;10(1):8418. doi: 10.1038/s41598-020-65423-0. Sci Rep. 2020. PMID: 32439965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical